Mohana, a pioneering health science company dedicated to empowering women navigating perimenopause, is thrilled to announce the successful completion of its latest funding round, successfully raising $1,000,000. This milestone comes as Mohana strives to transform the landscape of women’s health by providing essential tests, information, and tools tailored specifically for symptoms associated with hormonal changes during this critical life stage. The funding will be instrumental in further developing Mohana's precision platform, designed to simplify access to comprehensive hormonal health tests that help women understand their unique biochemical makeup. By analyzing biomarker data and other vital health information, Mohana matches users to the most effective, clinically-backed protocols tailored to their individual health journeys. With a commitment to fostering a community of informed women, Mohana aims not only to alleviate the challenges of perimenopause but also to help women feel more empowered and in control of their health. This funding marks a crucial step towards expanding the platform’s capabilities, enhancing educational resources, and broadening outreach to women who would benefit from Mohana's innovative approach to health management. As the company evolves, it remains steadfast in its mission to create a supportive environment where women can confidently embrace their health choices, making perimenopause a more manageable experience for all.
Empowering Women in Perimenopause: Mohana Secures $1 Million in Funding for Precision Health Science Platform
Get the full Mohana company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Anveshan
We are a food-tech startup aiming to provide high quality deeply traceable food products. We leverage technologies based on image processing, spectroscopy, blockchain and IOT to provide the best quality food products made traditionally.
$12.7M Series b
today
Caseway
We are the only enterprise AI form platform that replaces internal R&D and manual workflows by building and maintaining fully integrated automation systems, aligned to your data, your processes, and your long-term success. For document-intensive, compliance-driven organizations in regulated industries like insurance, education, finance, healthcare, and government Compelling reason to buy: Who need AI and automation tailored to their unique forms, workflows, and security environment, without having to shoulder R&D risk or manage AI development internally Product category: Our product is an enterprise document form platform Key benefit: That delivers a fully integrated, continuously improving automation system, built and maintained by experts, without upfront AI build costs Key differentiation: Our product is custom-built for each client’s systems and documents, fully integrated and continuously improved through a long-term partnership model, we maintain, debug, adapt, and align incentives to make it work in the real world.
$1.5M Pre-seed
today
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today